Browse complete U.S. Market for Orthopedic Biomaterials 2010 Report

Browse all iData Research Market Research Reports

In 2009, the orthopedic biomaterials market was valued at almost $3.5 billion. This market is expected to grow at a CAGR of 8.9% by 2016. The total orthopedic biomaterials market has experienced growth, despite the economic downturn, which began in 2008. The market started to spike in 2009 and peaked in 2010 largely driven by rapid growth in the stem cell, hyaluronic acid and synthetic bone graft substitute market segments.

This comprehensive report critically examines the following market segments:

Within the U.S. orthopedic biomaterials market, companies such as Arthrex, DePuy, Genzyme, Medtronic, Synthes and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004